Carrara Fabiola, Azzollini Nadia, Nattino Giovanni, Corna Daniela, Villa Sebastian, Cerullo Domenico, Zoja Carlamaria, Abrante Beatriz, Luis-Lima Sergio, Porrini Esteban, Cannata Antonio, Ferrari Silvia, Fois Matteo, Stucchi Nadia, Gaspari Flavio
Clinical Research Center for Rare Diseases x2018;Aldo and Cele Daccx00F2;', IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
Nephron. 2016;133(1):62-70. doi: 10.1159/000445843. Epub 2016 May 4.
BACKGROUND/AIMS: Glomerular filtration rate (GFR) is the best index for evaluating renal function. We aimed to develop a simplified iohexol plasma clearance procedure for GFR measurement in rats without urine collection, animal catheterization or anesthesia, with limited sampling and requiring blood instead of plasma, to further reduce the sample volume and improve animal welfare.
After iohexol injection (129.4 mg), samples were drawn according to 2-compartment kinetics and analyzed by high performance liquid chromatography. Healthy male Lewis rats were used to find a correction factor (CF) to obtain the 'reference clearance' from the simplified 1-comparment model. This approach was validated using male or female (Lewis, Sprague-Dawley) rats and animals with renal mass reduction (RMR). In additional rats, different simplified approaches were evaluated.
Iohexol concentrations in blood and plasma strongly correlated (r = 0.9784, p < 0.0001). A CF of 0.90 enabled the calculation of the reference GFR. Validation results in male Lewis rats were 0.99 ± 0.27 for the reference GFR and 1.03 ± 0.29 ml/min/100 g for the simplified approach. Results in female Sprague-Dawley rats confirmed the suitability of the proposed method. In RMR rats, GFR was 0.14 ± 0.05 and 0.14 ± 0.04 ml/min/100 g for the reference and simplified model, respectively.
The procedure we set up to measure GFR in conscious rats was proven to be reliable, required a small volume of blood at only 4 selected time points, without the need to collect urine or catheterize the animals, was applicable to rats from different strains and sexes, both healthy and with renal function impairment. Moreover, the procedure enables the monitoring of GFR changes over time in the same animal, thereby reducing the number of animals to be used.
背景/目的:肾小球滤过率(GFR)是评估肾功能的最佳指标。我们旨在开发一种简化的碘海醇血浆清除程序,用于在不收集尿液、不进行动物插管或麻醉的情况下测量大鼠的GFR,采样有限且需要血液而非血浆,以进一步减少样本量并改善动物福利。
注射碘海醇(129.4毫克)后,根据二室动力学采集样本,并通过高效液相色谱法进行分析。使用健康雄性Lewis大鼠找到校正因子(CF),以从简化的一室模型中获得“参考清除率”。使用雄性或雌性(Lewis、Sprague-Dawley)大鼠以及肾质量减少(RMR)的动物对该方法进行验证。在另外的大鼠中,评估了不同的简化方法。
血液和血浆中的碘海醇浓度高度相关(r = 0.9784,p < 0.0001)。CF为0.90时可计算参考GFR。雄性Lewis大鼠的验证结果显示,参考GFR为0.99 ± 0.27,简化方法为1.03 ± 0.29毫升/分钟/100克。雌性Sprague-Dawley大鼠的结果证实了所提出方法的适用性。在RMR大鼠中,参考模型和简化模型的GFR分别为0.14 ± 0.05和0.14 ± 0.04毫升/分钟/100克。
我们建立的用于测量清醒大鼠GFR的程序被证明是可靠的,仅在4个选定时间点需要少量血液,无需收集尿液或对动物进行插管,适用于不同品系和性别的大鼠,包括健康大鼠和肾功能受损大鼠。此外,该程序能够监测同一动物随时间的GFR变化,从而减少所需动物的数量。